Related Experiment Video

Updated: May 5, 2026

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems
06:18

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Published on: April 26, 2019

6.5K

Beyond Ribosomal Mutations: Identification of MPN_080 as a Novel ATPase-Dependent Determinant of Macrolide Resistance

Shaoli Li1,2,3, Yuyan Xia3, Fei Zhao4

  • 1Capital Institute of Pediatrics-Peking University Teaching Hospital, Beijing 100020, China.

Microorganisms
|May 4, 2026
PubMed

Insights

Macrolide resistance in Mycoplasma pneumoniae is a growing concern. This study identifies MPN_080, an ABC transporter, as a novel macrolide efflux pump contributing to this resistance.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genomics

Background:

  • Mycoplasma pneumoniae causes respiratory infections, with increasing macrolide resistance (MRMP) posing treatment challenges.
  • Previous research suggested macrolide efflux pumps, besides rRNA mutations, contribute to MRMP.
  • This study aimed to identify and confirm the role of a specific efflux pump in MRMP.

Purpose of the Study:

  • To identify the specific macrolide efflux pump in Mycoplasma pneumoniae.
  • To confirm the role of the identified pump in conferring macrolide resistance.
  • To investigate the mechanism and impact of this resistance on virulence.

Main Methods:

  • Comparative genomic analysis to identify candidate genes.
  • Phylogenetic analysis, AlphaFold structural modeling, and biochemical assays for characterization.
  • Gene overexpression studies in M129 strain to assess impact on Minimum Inhibitory Concentrations (MICs).

Main Results:

  • The ABC transporter permease gene, MPN_080, was identified as a candidate.
  • Overexpression of MPN_080 from a resistant isolate significantly increased erythromycin MICs.
  • The MPN_080-mediated resistance mechanism was independent of M. pneumoniae virulence factors.

Conclusions:

  • MPN_080 is a novel determinant of macrolide resistance in Mycoplasma pneumoniae.
  • This resistance mechanism involves enhanced ATPase activity of the ABC transporter.
  • Findings offer insights for developing new diagnostic and therapeutic strategies against MRMP.
Keywords:
ABC transporterMPN_080Mycoplasma pneumoniaeerythromycin resistance

More Related Videos

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

8.8K
Identification of Novel Genes Associated with Alginate Production in Pseudomonas aeruginosa Using Mini-himar1 Mariner Transposon-mediated Mutagenesis08:57

Identification of Novel Genes Associated with Alginate Production in Pseudomonas aeruginosa Using Mini-himar1 Mariner Transposon-mediated Mutagenesis

Published on: March 10, 2014

11.7K

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
Mutations in Microorganisms01:18

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
1.2K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K